- Home
- RCMT vs ARCT Comparison
RCMT vs ARCT Comparison
Compare RCMT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCMT | ARCT |
|---|---|---|
| Founded | 1971 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.8M | 293.9M |
| IPO Year | 1997 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RCMT | ARCT |
|---|---|---|
| Price | $37.07 | $9.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $45.00 | $23.80 |
| AVG Volume (30 Days) | 57.9K | ★ 627.1K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.38 | 20.00 |
| EPS | ★ 1.20 | N/A |
| Revenue | ★ $186,737,000.00 | $82,031,000.00 |
| Revenue This Year | $11.47 | N/A |
| Revenue Next Year | $10.09 | $64.21 |
| P/E Ratio | $31.30 | ★ N/A |
| Revenue Growth | ★ 5.83 | N/A |
| 52 Week Low | $17.26 | $5.50 |
| 52 Week High | $43.68 | $17.96 |
Technical Indicators
Market Signals| Indicator | RCMT | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 36.51 | 35.23 |
| Support Level | $27.02 | $6.53 |
| Resistance Level | $42.92 | $17.85 |
| Average True Range (ATR) | 1.49 | 1.01 |
| MACD | -0.48 | -0.27 |
| Stochastic Oscillator | 5.53 | 0.69 |
Price Performance
Historical ComparisonAbout RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions, including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, and Europe.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.